164 related articles for article (PubMed ID: 38022439)
1. The Spectrum of Intracranial Hypertrophic Pachymeningitis at an Eastern Indian Tertiary Care Center.
Das S; Ray BK
Ann Indian Acad Neurol; 2023; 26(5):678-689. PubMed ID: 38022439
[TBL] [Abstract][Full Text] [Related]
2. Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.
Gautier F; Neumann L; Adle-Biassete H; Rubenstein E; Bernat AL; Chimon A; Mouly S; Sène D; Comarmond C
Autoimmun Rev; 2023 Apr; 22(4):103285. PubMed ID: 36738953
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic Pachymeningitis in Chinese Patients: Presentation, Radiological Findings, and Clinical Course.
Bi Z; Shang K; Cao J; Su Z; Bu B; Xu S; Liu C
Biomed Res Int; 2020; 2020():2926419. PubMed ID: 32879880
[TBL] [Abstract][Full Text] [Related]
4. Distinct features of ANCA-associated hypertrophic pachymeningitis compared to other etiologies: findings from a study of 74 patients.
Martín-Nares E; Romero-Sánchez G; Cortez-Domínguez EU; Cano-Cruz LG; Hinojosa-Azaola A
Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38759113
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report.
Sergio P; Alejandro R; Cristian F
Reumatol Clin (Engl Ed); 2023; 19(6):338-344. PubMed ID: 37179159
[TBL] [Abstract][Full Text] [Related]
6. IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review.
Xia C; Li P
Front Neurol; 2022; 13():986694. PubMed ID: 36188377
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic Pachymeningitis in a Southern Chinese Population: A Retrospective Study.
Xiao X; Fu D; Feng L
Front Neurol; 2020; 11():565088. PubMed ID: 33281701
[No Abstract] [Full Text] [Related]
8. Imaging characteristics of hypertrophic pachymeningitis due to ANCA-associated vasculitis.
Takagi T; Okada M; Nakamura M; Hanari T; Nakata T; Teraoka M; Hato N
Auris Nasus Larynx; 2022 Oct; 49(5):875-879. PubMed ID: 35074241
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of hypertrophic pachymeningitis in a center survey.
Cação G; Calejo M; Alves JE; Medeiros PB; Vila-Cha N; Mendonça T; Taipa R; Silva AM; Damásio J
Neurol Sci; 2019 Mar; 40(3):543-551. PubMed ID: 30588552
[TBL] [Abstract][Full Text] [Related]
10. A Case of Hypertrophic Pachymeningitis Associated with Immunoglobulin-G4 and c-ANCA.
Wyrostek S; Chakrabarti S; Baldwin K; Avila JD
Case Rep Neurol; 2019; 11(3):290-294. PubMed ID: 31762760
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab.
Popkirov S; Kowalski T; Schlegel U; Skodda S
J Clin Neurosci; 2015 Jun; 22(6):1038-40. PubMed ID: 25861887
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights.
Shimojima Y; Sekijima Y
Autoimmun Rev; 2023 Jun; 22(6):103338. PubMed ID: 37062439
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic hypertrophic pachymeningitis at King Chulalongkorn Memorial Hospital.
Roongpiboonsopit D; Phanthumchinda K
J Med Assoc Thai; 2014 Apr; 97(4):374-80. PubMed ID: 24964678
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic hypertrophic cranial pachymeningitis: Three biopsy-proven cases including one case with abdominal pseudotumor and review of the literature.
Hassan KM; Deb P; Bhatoe HS
Ann Indian Acad Neurol; 2011 Jul; 14(3):189-93. PubMed ID: 22028532
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic pachymeningitis.
Hahn LD; Fulbright R; Baehring JM
J Neurol Sci; 2016 Aug; 367():278-83. PubMed ID: 27423604
[TBL] [Abstract][Full Text] [Related]
16. Clinical, imaging features and treatment response of idiopathic hypertrophic pachymeningitis.
Yao Y; Xu Y; Li X; Song T; Xu W; Duan Y; Liu Y; Zhang X; Tian DC
Mult Scler Relat Disord; 2022 Oct; 66():104026. PubMed ID: 35868153
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 15 cases with myeloperoxidase antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].
Guan WJ; Ding YX; Liu LJ; Li W; Jing LJ; Zhang X; Zhang LJ; Li H; Cheng SH; Liu SY
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):565-569. PubMed ID: 35488609
[TBL] [Abstract][Full Text] [Related]
18. A nationwide survey of hypertrophic pachymeningitis in Japan.
Yonekawa T; Murai H; Utsuki S; Matsushita T; Masaki K; Isobe N; Yamasaki R; Yoshida M; Kusunoki S; Sakata K; Fujii K; Kira J
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):732-9. PubMed ID: 24273222
[TBL] [Abstract][Full Text] [Related]
19. Optic neuropathy secondary to granulomatosis with polyangiitis in a patient with Graves' disease: a case report.
Sato-Akushichi M; Kinouchi R; Kawai N; Nomura K
J Med Case Rep; 2021 Dec; 15(1):618. PubMed ID: 34963497
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review.
Melenotte C; Seguier J; Ebbo M; Kaphan E; Bernit E; Saillier L; Audoin B; Feyeux D; Daniel L; Roche PH; Graillon T; Dufour H; Boutière C; Girard N; Closs-Prophette F; Guillaud C; Tieulié N; Regent A; Harlé JR; Hamidou M; Mekinian A; Grados A; Schleinitz N
Semin Arthritis Rheum; 2019 Dec; 49(3):430-437. PubMed ID: 31155444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
